Guide to buying Regencell Bioscience stock in Canada

Regencell Bioscience is a drug manufacturers - specialty & generic business based in the US. Regencell Bioscience stocks (RGC) are listed on the NASDAQ, and all prices are listed in US Dollars.

Regencell Bioscience employs 10 staff and has a market cap (total outstanding shares value) of $6.1 billion.

Keep reading to see up-to-date Regencell Bioscience stock price and performance data, along with a step-by-step guide for how to buy Regencell Bioscience stock in Canada.

Regencell Bioscience (RGC) stock summary

Company stock name	Regencell Bioscience Holdings Ltd
Stock ticker symbol	RGC
Exchange	NASDAQ
Open	$11.51
High	$12.25
Low	$10.50
Close	$11.95
Adjusted closing	$11.95
Volume The number of stocks traded during the day	131,200
52-week stock price range	$0.09 – $83.60
Where to buy Regencell Bioscience stock	Buy on CIBC Investor's Edge

The values in this table are accurate as of the market close on November 30, 2025, and all amounts are in USD.

Can I buy Regencell Bioscience stock in Canada?

Yes, you can buy Regencell Bioscience stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NASDAQ exchange. Platforms like Interactive Brokers will allow you to directly buy Regencell Bioscience stock from within Canada.

Dive deeper: Detailed guide on how to buy stocks in Canada

Our top picks for where to buy Regencell Bioscience stock

Regencell Bioscience stock chart (NASDAQ: RGC)

This chart tracks Regencell Bioscience stock price performance over time.

Regencell Bioscience stock price

Regencell Bioscience's stock price at the last available market close was $11.95 (as of November 30, 2025). Keep in mind that Regencell Bioscience's stock price can be impacted on a daily, or even hourly, basis by factors like company performance, the broader economy and investor sentiments.

Is Regencell Bioscience stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for Regencell Bioscience stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy Regencell Bioscience stock on the TSX?

No, you cannot buy Regencell Bioscience stock on the TSX because Regencell Bioscience stock is not listed on the TSX. Instead, Regencell Bioscience stock is listed on the NASDAQ under the symbol "RGC."

That said, if you're wondering how to invest in Regencell Bioscience stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NASDAQ, like Interactive Brokers.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Regencell Bioscience stock dividends

Regencell Bioscience is not expected to pay a dividend over the next 12 months. We'll continue to monitor Regencell Bioscience's stock information and update this guide if that changes.

Regencell Bioscience stock performance metrics

Here are some common key metrics for Regencell Bioscience stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

• Regencell Bioscience's P/E ratio

  Regencell Bioscience's current share price divided by its per-share earnings (EPS) over the past 12 months gives a trailing price/earnings (P/E) ratio of roughly 0x. In other words, Regencell Bioscience shares trade at around 0 times recent earnings.

  That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

• Regencell Bioscience's PEG ratio

  Regencell Bioscience's price/earnings-to-growth (PEG) ratio is calculated by dividing its P/E ratio by its earnings growth, which comes out to about None. A lower ratio can suggest a stock offers better value, while a higher ratio may suggest worse value.

  The PEG ratio provides a broader view than the P/E ratio alone, as it factors in Regencell Bioscience's expected earnings growth. By accounting for growth, investors can use the PEG ratio to compare the valuations of multiple high-growth companies.

Has Regencell Bioscience stock ever split?

Regencell Bioscience's stocks were split on a 38:1 basis on June 15, 2025. So, if you had owned 1 share the day before before the split, the next day you'd have owned 38 shares. This wouldn't directly have changed the overall worth of your Regencell Bioscience stocks, just the quantity.

However, indirectly, the new 97.4% lower stock price could have impacted the market appetite for Regencell Bioscience stocks, which in turn could have impacted Regencell Bioscience's stock price.

How volatile is Regencell Bioscience stock?

Over the last 12 months, Regencell Bioscience's stocks price has ranged from $0.09 to as high as $83.60. Regencell Bioscience's beta measurement of stock volatility is 2.00. For comparison, the market () average beta is 1. This would suggest that Regencell Bioscience's stocks are significantly more volatile than the average for this exchange and represent a higher risk.

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of Regencell Bioscience's beta stock volatility rating.

Regencell Bioscience Holdings Ltd company and revenue performance

Market Capitalization The total market value of Regencell Bioscience's outstanding shares	$6.1 billion
Gross profit (TTM)	$0
Profit margin	0.00%
Return on assets (TTM)	-33.20%
Return on equity (TTM)	-54.81%
Earnings per share (TTM)	-$0.01
50-day moving stock price average The average share price over the last 50 days	$15.13
200-day moving stock price average The average share price over the last 200 days	$11.69

All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on December 4, 2025.

Regencell Bioscience company profile

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.

The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

• Common company-related questions about Regencell Bioscience

  What percentage of Regencell Bioscience is owned by insiders or institutions?
  Currently 88.555% of Regencell Bioscience stocks are held by insiders and 0.129% by institutions.

  How many people work for Regencell Bioscience?
  Latest data suggests 10 work at Regencell Bioscience.

  When does the fiscal year end for Regencell Bioscience?
  Regencell Bioscience's fiscal year ends in June.

  Where is Regencell Bioscience based?
  Regencell Bioscience's address is: Chinachem Leighton Plaza, Causeway Bay, Hong Kong

  What is Regencell Bioscience's ISIN number?
  Regencell Bioscience's international securities identification number is: KYG7487R1002

Compare trading platforms to buy Regencell Bioscience Holdings Limited stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

Related: Compare the best stock trading platforms in Canada

Do I have to pay tax on gains from Regencell Bioscience stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling Regencell Bioscience stock. The CRA taxes investment income from stocks in Canada based on three main factors:

1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about Regencell Bioscience stock

• Can I buy Regencell Bioscience stock directly as a Canadian investor?

  Yes, Canadian investors can buy Regencell Bioscience stock directly through various online brokerage platforms available in Canada. You can compare trading platform options and fees for buying Regencell Bioscience stock in our table here.

• Can Canadians buy American stocks?

  Yes, Canadians can buy American stocks through Canadian trading platforms that give access to American stock exchanges such as the NYSE and Nasdaq. The good news is that most Canadian brokerage platforms, like Questrade, Interactive Brokers, Moomoo and Wealthsimple, give access to US exchanges. Read our full guide on how to buy US stocks in Canada to learn more.

• Can I buy fractional shares of Regencell Bioscience stock?

  Yes, it may be possible to buy fractional shares of Regencell Bioscience stock depending on the trading platform you're signed up with. Fractional shares can allow you to invest in Regencell Bioscience stock even when you can't afford its full share price. You can read our full guide to how fractional shares work to learn more.

  The table below shows trading apps in Canada that offer fractional shares:

  3 of 3 results

  Finder Score	Available Asset Types	Account Types	Stock Trading Fee	Monthly Account Fee
  Promoted Finder Score 8.8 Great Interactive Brokers	Finder Score 8.8 Great	Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures	RRSP, TFSA, Personal, Joint	min $1.00, max 0.5%	$0	Go to site More info Compare product selection Compare	loading
  Finder Score 7.4 Great Moomoo Financial Canada	Finder Score 7.4 Great	Stocks, Options, ETFs	RRSP, TFSA, Personal, FHSA	$1.49/stock	$0	Get up to $4,600 in trading perks. T&Cs apply.	Go to site More info Compare product selection Compare	loading
  Finder Score 9.1 Excellent Questrade	Finder Score 9.1 Excellent	Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs	RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA	$0	$0	Get free contracts, no commissions and a 30 day free trial of Questrade Plus. Use offer code FREEOPTIONS. T&Cs apply.	Go to site More info Compare product selection Compare	loading

  loading

  Load More

  Showing 3 of 3 results

  Finder Score for stock trading platforms

  To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

  Read the full methodology

Related: New to stock trading? Compare brokers and get tips for investing.

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.